SLPQualitativeAutism : the international journal of research and practice2025

The impact of state policy on early autism diagnosis: A qualitative investigation.

Olivia J Lindly, Danielle Abate, Plyce L Fuchu and 5 others

PMID 40401335

WHAT IT FOUND

Experts identified state policy gaps as primary drivers of delayed autism diagnosis.

Screening mandates are inconsistent, insurance requirements restrict diagnostic providers, and Medicaid reimbursement rates create significant access barriers. These systemic factors, rather than clinical practice alone, dictate how quickly families receive evaluations and services.

Key findings

01Variability in state policies affects screening periodicity and tools, with no federal mandate requiring autism-specific screening at recommended ages.

02Insurance and state regulations often require diagnoses from specific provider types (e.g., MDs, PhDs), creating workforce bottlenecks and long wait times.

03Children in Early Intervention may age out of services before receiving a medical diagnosis due to evaluation delays, creating a 'service cliff'.

STILL TO COME

How it was doneWhat they foundWhat it means for SLPs

Read the rest of this summary

You get three full summaries a month, free, and we do not ask for a card. Search, the TL;DRs and your library stay unlimited either way.

Already have one?

What it does not show

The study focused on policy related to diagnosis rather than treatment services. Inter-rater reliability was not formally calculated during coding, though post-hoc checks showed good agreement. Participants represented only five states primarily, limiting generalizability to other regions. Findings rely on participant perspectives and may not reflect complete policy knowledge.

Declared interests

The study was supported by the National Institutes of Health. No other conflicts of interest were reported in the text.

The easy way to misread this

Do not interpret these findings as evidence that specific clinical interventions improve diagnosis speed. The study identifies systemic policy and insurance barriers that delay access, not the efficacy of therapeutic techniques.

Read it on PubMed →